Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Evergy
EVRG
$19.1B
| $62.8M | 0.06% |
1,056,593
| – | – |
|
152
KBR
KBR
$4.62B
| $62.3M | 0.06% |
1,442,525
+608,191
| +73% | +$29.9M |
|
153
WEX
WEX
$6.37B
| $62.3M | 0.06% |
490,765
+73,000
| +17% | +$11.5M |
|
154
Darling Ingredients
DAR
$9.64B
| $62M | 0.06% |
937,781
+229,068
| +32% | +$16M |
|
155
Kontoor Brands
KTB
$4.63B
| $60.2M | 0.06% |
1,790,775
+368,007
| +26% | +$13.6M |
|
156
Jazz Pharmaceuticals
JAZZ
$15.9B
| $59.4M | 0.06% |
445,761
+136,361
| +44% | +$20.7M |
|
|
KNBE
157
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $59M | 0.06% |
2,836,534
+747,162
| +36% | +$13.8M |
|
158
SBA Communications
SBAC
$19.2B
| $58.9M | 0.06% |
206,980
+10,142
| +5% | +$3.29M |
|
159
General Motors
GM
$80.4B
| $58.4M | 0.06% |
1,818,945
-51,218
| -3% | -$1.88M |
|
160
Independence Realty Trust
IRT
$3.92B
| $57.7M | 0.06% |
3,445,975
+137,043
| +4% | +$2.77M |
|
161
Ryan Specialty Holdings
RYAN
$5.72B
| $57.5M | 0.06% |
1,416,004
-266,041
| -16% | -$11.2M |
|
162
Huron Consulting
HURN
$2.41B
| $56.9M | 0.06% |
858,446
+274,508
| +47% | +$18.2M |
|
163
Alexandria Real Estate Equities
ARE
$8.97B
| $56.8M | 0.06% |
404,876
+60,735
| +18% | +$9.32M |
|
|
ETRN
164
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $55.6M | 0.06% |
7,428,814
+6,104,736
| +461% | +$51.1M |
|
165
Patterson-UTI
PTEN
$3.98B
| $55.4M | 0.06% |
4,746,249
+465,518
| +11% | +$6.65M |
|
|
CDMO
166
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $55M | 0.05% |
2,876,669
+1,005,100
| +54% | +$18.3M |
|
|
NSA
167
DELISTED
National Storage Affiliates Trust
NSA
| $54.9M | 0.05% |
1,319,805
-4,751
| -0.4% | -$242K |
|
168
Zurn Elkay Water Solutions
ZWS
$8.38B
| $54.6M | 0.05% |
2,226,690
+404,471
| +22% | +$11.5M |
|
169
Bloomin' Brands
BLMN
$741M
| $53.7M | 0.05% |
2,927,286
+404,708
| +16% | +$8.04M |
|
170
Lam Research
LRCX
$367B
| $53.5M | 0.05% |
1,461,150
+6,080
| +0.4% | +$271K |
|
|
ROIC
171
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $53.2M | 0.05% |
3,869,038
+1,798,180
| +87% | +$29.7M |
|
172
Eastern Bankshares
EBC
$5.26B
| $53.1M | 0.05% |
2,701,764
+430,561
| +19% | +$8.61M |
|
173
e.l.f. Beauty
ELF
$4.89B
| $52.9M | 0.05% |
1,407,360
-344,949
| -20% | -$12.5M |
|
174
Brunswick
BC
$5.13B
| $52.9M | 0.05% |
808,198
-73,325
| -8% | -$5.5M |
|
|
Y
175
DELISTED
Alleghany Corp
Y
| $50.7M | 0.05% |
60,393
+11,232
| +23% | +$9.42M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.